Loading…

Albumin as a prognostic marker for ulcerative colitis

AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i....

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG 2017-12, Vol.23 (45), p.8008-8016
Main Authors: Khan, Nabeel, Patel, Dhruvan, Shah, Yash, Trivedi, Chinmay, Yang, Yu-Xiao
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143
cites cdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143
container_end_page 8016
container_issue 45
container_start_page 8008
container_title World journal of gastroenterology : WJG
container_volume 23
creator Khan, Nabeel
Patel, Dhruvan
Shah, Yash
Trivedi, Chinmay
Yang, Yu-Xiao
description AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,> 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.
doi_str_mv 10.3748/wjg.v23.i45.8008
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5725295</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849555253484856</cqvip_id><sourcerecordid>1979174816</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMoWqt3T7JHL1vzuUkuQil-geBFzyGbpNvU7aYmuxX_vSmtRXOZwDzzzvAAcIXghHAqbr-WzWSDycRTNhEQiiMwwhjJEgsKj8EIQchLSTA_A-cpLSHEhDB8Cs6wxEwSXo0Am7b1sPJdoVOhi3UMTRdS702x0vHDxWIeYjG0xkXd-40rTGh979MFOJnrNrnLfR2D94f7t9lT-fL6-DybvpSGUtiX2hqsreCVQQhSYi01HHFLsBSM40ozSypbazOH0NWIVrgWNXKWZYoyjCgZg7td7nqoV84a1_VRt2odfT7vWwXt1f9O5xeqCRuV4xmWLAfc7ANi-Bxc6tXKJ-PaVncuDEkhySXKJlGVUbhDTQwpRTc_rEFQbW2rbFtl2yrbVlvbeeT673mHgV-9GSD7zEXomk_fNQdGQrF9kkEqqGSMYUbyT7CK_ABDQowC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1979174816</pqid></control><display><type>article</type><title>Albumin as a prognostic marker for ulcerative colitis</title><source>PubMed Central</source><creator>Khan, Nabeel ; Patel, Dhruvan ; Shah, Yash ; Trivedi, Chinmay ; Yang, Yu-Xiao</creator><creatorcontrib>Khan, Nabeel ; Patel, Dhruvan ; Shah, Yash ; Trivedi, Chinmay ; Yang, Yu-Xiao</creatorcontrib><description>AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,&amp;gt; 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v23.i45.8008</identifier><identifier>PMID: 29259376</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Adult ; Aged ; Biomarkers - blood ; Colectomy ; Colitis, Ulcerative - blood ; Colitis, Ulcerative - diagnosis ; Colitis, Ulcerative - therapy ; Female ; Follow-Up Studies ; Humans ; Hypoalbuminemia - blood ; Immunosuppressive Agents - therapeutic use ; Male ; Middle Aged ; Prognosis ; Retrospective Cohort Study ; Retrospective Studies ; Risk Factors ; Serum Albumin - analysis ; Severity of Illness Index ; Time Factors ; Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors ; United States ; United States Department of Veterans Affairs - statistics &amp; numerical data</subject><ispartof>World journal of gastroenterology : WJG, 2017-12, Vol.23 (45), p.8008-8016</ispartof><rights>The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. 2017</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</citedby><cites>FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725295/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725295/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29259376$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Nabeel</creatorcontrib><creatorcontrib>Patel, Dhruvan</creatorcontrib><creatorcontrib>Shah, Yash</creatorcontrib><creatorcontrib>Trivedi, Chinmay</creatorcontrib><creatorcontrib>Yang, Yu-Xiao</creatorcontrib><title>Albumin as a prognostic marker for ulcerative colitis</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,&amp;gt; 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Biomarkers - blood</subject><subject>Colectomy</subject><subject>Colitis, Ulcerative - blood</subject><subject>Colitis, Ulcerative - diagnosis</subject><subject>Colitis, Ulcerative - therapy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypoalbuminemia - blood</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prognosis</subject><subject>Retrospective Cohort Study</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>Serum Albumin - analysis</subject><subject>Severity of Illness Index</subject><subject>Time Factors</subject><subject>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</subject><subject>United States</subject><subject>United States Department of Veterans Affairs - statistics &amp; numerical data</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMoWqt3T7JHL1vzuUkuQil-geBFzyGbpNvU7aYmuxX_vSmtRXOZwDzzzvAAcIXghHAqbr-WzWSDycRTNhEQiiMwwhjJEgsKj8EIQchLSTA_A-cpLSHEhDB8Cs6wxEwSXo0Am7b1sPJdoVOhi3UMTRdS702x0vHDxWIeYjG0xkXd-40rTGh979MFOJnrNrnLfR2D94f7t9lT-fL6-DybvpSGUtiX2hqsreCVQQhSYi01HHFLsBSM40ozSypbazOH0NWIVrgWNXKWZYoyjCgZg7td7nqoV84a1_VRt2odfT7vWwXt1f9O5xeqCRuV4xmWLAfc7ANi-Bxc6tXKJ-PaVncuDEkhySXKJlGVUbhDTQwpRTc_rEFQbW2rbFtl2yrbVlvbeeT673mHgV-9GSD7zEXomk_fNQdGQrF9kkEqqGSMYUbyT7CK_ABDQowC</recordid><startdate>20171207</startdate><enddate>20171207</enddate><creator>Khan, Nabeel</creator><creator>Patel, Dhruvan</creator><creator>Shah, Yash</creator><creator>Trivedi, Chinmay</creator><creator>Yang, Yu-Xiao</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171207</creationdate><title>Albumin as a prognostic marker for ulcerative colitis</title><author>Khan, Nabeel ; Patel, Dhruvan ; Shah, Yash ; Trivedi, Chinmay ; Yang, Yu-Xiao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Biomarkers - blood</topic><topic>Colectomy</topic><topic>Colitis, Ulcerative - blood</topic><topic>Colitis, Ulcerative - diagnosis</topic><topic>Colitis, Ulcerative - therapy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypoalbuminemia - blood</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prognosis</topic><topic>Retrospective Cohort Study</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>Serum Albumin - analysis</topic><topic>Severity of Illness Index</topic><topic>Time Factors</topic><topic>Tumor Necrosis Factor-alpha - antagonists &amp; inhibitors</topic><topic>United States</topic><topic>United States Department of Veterans Affairs - statistics &amp; numerical data</topic><toplevel>online_resources</toplevel><creatorcontrib>Khan, Nabeel</creatorcontrib><creatorcontrib>Patel, Dhruvan</creatorcontrib><creatorcontrib>Shah, Yash</creatorcontrib><creatorcontrib>Trivedi, Chinmay</creatorcontrib><creatorcontrib>Yang, Yu-Xiao</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Nabeel</au><au>Patel, Dhruvan</au><au>Shah, Yash</au><au>Trivedi, Chinmay</au><au>Yang, Yu-Xiao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Albumin as a prognostic marker for ulcerative colitis</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2017-12-07</date><risdate>2017</risdate><volume>23</volume><issue>45</issue><spage>8008</spage><epage>8016</epage><pages>8008-8016</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM To evaluate the role of albumin at the time of ulcerative colitis(UC) diagnosis in predicting the clinical course of disease.METHODS Nationwide cohort of patients with newly diagnosed UC in the Veterans Affairs health care system was identified and divided into two categories: hypoalbuminemia(i.e.,≤ 3.5 gm/dl) or normal albumin levels(i.e.,&amp;gt; 3.5 gm/dl) at the time of UC diagnosis. The exposure of interest was presence of hypoalbuminemia defined asalbumin level ≤ 3.5 g/dl at the time of UC diagnosis. Patients were then followed over time to identify the use of ≥ 2 courses of corticosteroids(CS),thiopurines,anti-TNF medications and requirement of colectomy for UC management. RESULTS The eligible study cohort included 802 patients,but 92(11.4%) patients did not have their albumin levels checked at the time of UC diagnosis,and they were excluded. A total of 710 patients,who had albumin levels checked at time of UC diagnosis,were included in our study. Amongst them,536 patients had a normal albumin level and 174 patients had hypoalbuminemia. Patients with hypoalbuminemia at diagnosis had a higher likelihood of ≥ 2 courses of CS use(adjusted HR = 1.7,95%CI: 1.3-2.3),higher likelihood of thiopurine or anti-TNF use(adjusted HR = 1.72,95%CI: 1.23-2.40) than patients with normal albumin level at diagnosis. There was a trend of higher likelihood of colectomy in hypoalbuminemic patients,but it was not statistically significant(Adjusted HR = 1.7,95%CI: 0.90-3.25).CONCLUSION Hypoalbuminemia at disease diagnosis can serve as a prognostic marker to predict the clinical course of UC at the time of diagnosis.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>29259376</pmid><doi>10.3748/wjg.v23.i45.8008</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1007-9327
ispartof World journal of gastroenterology : WJG, 2017-12, Vol.23 (45), p.8008-8016
issn 1007-9327
2219-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5725295
source PubMed Central
subjects Adrenal Cortex Hormones - therapeutic use
Adult
Aged
Biomarkers - blood
Colectomy
Colitis, Ulcerative - blood
Colitis, Ulcerative - diagnosis
Colitis, Ulcerative - therapy
Female
Follow-Up Studies
Humans
Hypoalbuminemia - blood
Immunosuppressive Agents - therapeutic use
Male
Middle Aged
Prognosis
Retrospective Cohort Study
Retrospective Studies
Risk Factors
Serum Albumin - analysis
Severity of Illness Index
Time Factors
Tumor Necrosis Factor-alpha - antagonists & inhibitors
United States
United States Department of Veterans Affairs - statistics & numerical data
title Albumin as a prognostic marker for ulcerative colitis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T13%3A09%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Albumin%20as%20a%20prognostic%20marker%20for%20ulcerative%20colitis&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Khan,%20Nabeel&rft.date=2017-12-07&rft.volume=23&rft.issue=45&rft.spage=8008&rft.epage=8016&rft.pages=8008-8016&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v23.i45.8008&rft_dat=%3Cproquest_pubme%3E1979174816%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-adc2ad876c11043dd4c717d32985726a5d36dbacf00eb1462b8b1ed5c71452143%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1979174816&rft_id=info:pmid/29259376&rft_cqvip_id=90888889504849555253484856&rfr_iscdi=true